AMNEAL PHARMACEUTICALS, INC. (AMRX) Net margin 2016–2025
AMNEAL PHARMACEUTICALS, INC. (AMRX) net profit margin by fiscal year — reported net income divided by reported revenue.
2.4%FY2025 · since FY2016: 0.0% → 2.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2.4% | +6.6 pp |
| FY2024 | -4.2% | -0.7 pp |
| FY2023 | -3.5% | +8.7 pp |
| FY2022 | -12.2% | -12.9 pp |
| FY2021 | 0.6% | -2.8 pp |
| FY2020 | 3.4% | +40.5 pp |
| FY2019 | -37.1% | -35.9 pp |
| FY2018 | -1.2% | -1.2 pp |
| FY2017 | 0.0% | +0.0 pp |
| FY2016 | 0.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice